Veracyte, Inc. (VCYT): Depreciation & Amortization
$21.41M
Year ended 2025-12-31
$20.83M
Trailing 12 months to 2026-06-30
-6.2%
3-year compound annual growth
+21.9%
5-year compound annual growth
+25.2%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $21.41M | -8.7% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $23.46M | -13.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $27.19M | +4.9% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $25.93M | +32.3% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $19.59M | +146.6% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $7.94M | +93.0% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $4.12M | +5.0% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $3.92M | +2.1% | 2021-02-22, From 2018-01-01 |
| 2017-12-31 | $3.84M | +9.4% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $3.51M | +55.8% | 2019-02-25, From 2016-01-01 |
| 2015-12-31 | $2.25M | +91.8% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $1.18M | +17.6% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $999.0K | +41.5% | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | $706.0K | +15.5% | 2015-03-25, From 2012-01-01 |
| 2011-12-31 | $611.0K | n/a | 2014-03-20, From 2011-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Veracyte, Inc. (VCYT) | 2025-12-31 | $21.41M | -8.7% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $15.02M | +5.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $40.77M | +154.9% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $22.61M | -53.8% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $24.12M | -3.2% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $6.90M | -1.4% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $39.74M | -6.3% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $136.10M | +8.6% |
| Natera, Inc. (NTRA) | 2025-12-31 | $41.76M | +34.9% |
Compare VCYT, CDNA, CSTL, CAI side by side · Screen every company in Services-Medical Laboratories ↗